Escrow-release deadline extended for Canaccord deal with Columbia Care

Canaccord Genuity Growth Corp. (CGG) yesterday provided an update on its agreement with Columbia Care, a leading medical cannabis company in the United States.

CGG has obtained approval to extend the Escrow Release Deadline, as per an amendment of the subscription receipt agreement terms. Continue reading Escrow-release deadline extended for Canaccord deal with Columbia Care

Multiple clinical-trial records on negative aspects of cannabis were updated this week.

Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today.  Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria.  Continue reading Multiple clinical-trial records on negative aspects of cannabis were updated this week.

Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.

Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.

Aphria signs deal; exclusive global partner for QuickStrip

Aphria and Canadian bio-technology company Rapid Dose Therapeutics have signed an MOU that Aphria will have exclusive global preferred rights to produce, distribute and sell QuickStrip(TM) products for cannabis markets around the world, once a definitive agreement is signed between the two companies in the near future. Continue reading Aphria signs deal; exclusive global partner for QuickStrip

Fatty acid hurts PTSD healing

Brand new research shows that if the body’s Anandamide levels can be prevented from falling, PTSD treatment may be more effective. Anandamide is the human cannabinoid that’s sometimes called the bliss molecule. The study shows that putting stress on the brain can cause a drop in Anandamide levels. On the other hand, protecting the brain from stress causes Anandamide levels to go up. The culprit causing the levels to fall is  a fatty acid called FAAH. The FAAH  hits parts of the brain involved in fear extinction, which means it’s nearly impossible to completely forget the  cary or terrifying events that led … Continue reading Fatty acid hurts PTSD healing

New discovery: cannabinoid that reduces inflammation in the intestines.

The discovery of a new molecule that’s similar to the Anandamide molecule  is creating a buzz. We already know that the cannabinoids CBD and THC are powerful anti-inflammatories. Now a new cannabinoid –  PEA – has been found to benefit the gastrointestinal system. PEA reduces inflammation in the intestine when it connects with cannabinoid receptors CB1 and CB2 and the new kid on the block – CB3. No doubt – more discoveries to come! Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts … Continue reading New discovery: cannabinoid that reduces inflammation in the intestines.

Cannabis smoking doesn’t increase risk of getting head, neck and lung cancer, but tobacco use does.

Founded in 1863 through a congressional charter signed by President Lincoln, the National Academies of Sciences, Engineering and Medicine produced its report Health Effects of Marijuana and Cannabis-Derived Products in 2017. It found that : Continue reading Cannabis smoking doesn’t increase risk of getting head, neck and lung cancer, but tobacco use does.